Cécile P.M. Janus

2.7k total citations · 2 hit papers
33 papers, 1.3k citations indexed

About

Cécile P.M. Janus is a scholar working on Pathology and Forensic Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Cécile P.M. Janus has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Cécile P.M. Janus's work include Lymphoma Diagnosis and Treatment (18 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers) and Breast Cancer Treatment Studies (8 papers). Cécile P.M. Janus is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers) and Breast Cancer Treatment Studies (8 papers). Cécile P.M. Janus collaborates with scholars based in Netherlands, United Kingdom and Denmark. Cécile P.M. Janus's co-authors include Flora E. van Leeuwen, Berthe M.P. Aleman, Michael Schaapveld, Frederika A. van Nimwegen, Augustinus D. G. Krol, Michael Hauptmann, David J. Cutter, Sarah C. Darby, John Raemaekers and Eefke Petersen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Cécile P.M. Janus

30 papers receiving 1.3k citations

Hit Papers

Cardiovascular Disease After Hodgkin Lymphoma Treatment 2015 2026 2018 2022 2015 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiovascular Disease After Hodgkin Lymphoma Treatment
    2015 358 citations Frederika A. van Nimwegen, Michael Schaapveld et al. profile →
  2. Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
    2015 324 citations Frederika A. van Nimwegen, Michael Schaapveld et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cécile P.M. Janus Netherlands 13 679 499 368 357 266 33 1.3k
Maja V. Maraldo Denmark 19 346 0.5× 451 0.9× 534 1.5× 419 1.2× 186 0.7× 59 1.3k
Wil V. Dolsma Netherlands 19 214 0.3× 190 0.4× 240 0.7× 235 0.7× 432 1.6× 27 1.1k
Robert G. Prosnitz United States 17 393 0.6× 425 0.9× 333 0.9× 144 0.4× 356 1.3× 39 1.3k
Torgil R. Möller Sweden 17 161 0.2× 171 0.3× 349 0.9× 211 0.6× 460 1.7× 29 1.3k
U. Blom-Goldman Sweden 3 960 1.4× 1.1k 2.3× 907 2.5× 266 0.7× 620 2.3× 4 2.8k
Jennifer Wilkinson United Kingdom 17 46 0.1× 350 0.7× 279 0.8× 259 0.7× 244 0.9× 38 1.3k
Anton Kruger United Kingdom 13 107 0.2× 215 0.4× 239 0.6× 918 2.6× 512 1.9× 26 1.2k
Neil K. Taunk United States 18 189 0.3× 329 0.7× 295 0.8× 72 0.2× 278 1.0× 102 985
Akthar Shamsaldin France 11 66 0.1× 125 0.3× 216 0.6× 72 0.2× 227 0.9× 11 768
M. Beauduin Belgium 18 118 0.2× 160 0.3× 330 0.9× 90 0.3× 662 2.5× 70 1.2k

Countries citing papers authored by Cécile P.M. Janus

Since Specialization
Citations

This map shows the geographic impact of Cécile P.M. Janus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile P.M. Janus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile P.M. Janus more than expected).

Fields of papers citing papers by Cécile P.M. Janus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile P.M. Janus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile P.M. Janus. The network helps show where Cécile P.M. Janus may publish in the future.

Co-authorship network of co-authors of Cécile P.M. Janus

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile P.M. Janus. A scholar is included among the top collaborators of Cécile P.M. Janus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile P.M. Janus. Cécile P.M. Janus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Russell, Nicola S., Ruth M. Pfeiffer, Inge M. Krul, et al.. (2025). Radiation Doses to the Breast and Predicted Breast Cancer Risk Among Patients Treated for Hodgkin Lymphoma With Modern Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 122(1). 63–71.
2.
Shakir, Rebecca, Georgios Ntentas, Marianne Aznar, et al.. (2023). Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma. JAMA Oncology. 9(4). 481–481. 5 indexed citations
3.
Vries, Simone de, Inge M. Krul, Michael Schaapveld, et al.. (2023). Risk of male breast cancer after Hodgkin lymphoma. Blood. 142(9). 806–811. 4 indexed citations
4.
Heemsbergen, Wilma D., Cécile P.M. Janus, M. van de Pol, et al.. (2023). Impact of Advanced External Beam Radiotherapy on Second Haematological Cancer Risk in Prostate Cancer Survivors. Clinical Oncology. 35(4). e278–e288.
5.
Aleman, Berthe M.P., Umberto Ricardi, Richard W.M. van der Maazen, et al.. (2023). A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer/Lymphoma Study Association/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned. International Journal of Radiation Oncology*Biology*Physics. 117(3). 664–674. 3 indexed citations
6.
Kiciński, Michal, Michael Schaapveld, Berthe M.P. Aleman, et al.. (2022). Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on theEORTC‐Dutchlate effects cohort‐linked data. European Journal Of Haematology. 110(3). 243–252. 1 indexed citations
7.
Gini, Andrea, Manon C.W. Spaander, Leon M.G. Moons, et al.. (2022). Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy. Cancer Epidemiology Biomarkers & Prevention. 31(12). 2157–2168. 3 indexed citations
8.
Janus, Cécile P.M., Daniel J. Bowen, H. Carlijne Hassing, et al.. (2021). Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors. JACC CardioOncology. 3(5). 695–706. 19 indexed citations
9.
Rossi, Linda, Cécile P.M. Janus, M. van de Pol, et al.. (2021). On the Importance of Individualized, Non-Coplanar Beam Configurations in Mediastinal Lymphoma Radiotherapy, Optimized With Automated Planning. Frontiers in Oncology. 11. 619929–619929. 14 indexed citations
10.
Eggermond, Anna M. van, Michael Schaapveld, Cécile P.M. Janus, et al.. (2017). Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. British Journal of Cancer. 117(3). 306–314. 18 indexed citations
11.
Nimwegen, Frederika A. van, Georgios Ntentas, Sarah C. Darby, et al.. (2017). Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood. 129(16). 2257–2265. 161 indexed citations
12.
Cutter, David J., Michael Schaapveld, Sarah C. Darby, et al.. (2015). Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma. JNCI Journal of the National Cancer Institute. 107(4). 215 indexed citations
13.
Nimwegen, Frederika A. van, David J. Cutter, Michael Schaapveld, et al.. (2015). Simple Method to Estimate Mean Heart Dose From Hodgkin Lymphoma Radiation Therapy According to Simulation X-Rays. International Journal of Radiation Oncology*Biology*Physics. 92(1). 153–160. 8 indexed citations
14.
Pignol, Jean‐Philippe & Cécile P.M. Janus. (2015). The evaluation of innovation in radiation oncology – what can we do and what should we do?. Acta Oncologica. 54(9). 1251–1253. 13 indexed citations
15.
Nimwegen, Frederika A. van, Michael Schaapveld, David J. Cutter, et al.. (2015). Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma. Journal of Clinical Oncology. 34(3). 235–243. 324 indexed citations breakdown →
16.
Nimwegen, Frederika A. van, Michael Schaapveld, Cécile P.M. Janus, et al.. (2014). Risk of Diabetes Mellitus in Long-Term Survivors of Hodgkin Lymphoma. Journal of Clinical Oncology. 32(29). 3257–3263. 76 indexed citations
17.
Schaapveld, Michael, Anna M. van Eggermond, Cécile P.M. Janus, et al.. (2014). Cause-specific mortality among patients with Hodgkin lymphoma (HL) up to 40 years after treatment.. Journal of Clinical Oncology. 32(15_suppl). 9517–9517. 2 indexed citations
18.
Nimwegen, Frederika A. van, Michael Schaapveld, Cécile P.M. Janus, et al.. (2014). Cardiovascular diseases after Hodgkin lymphoma treatment: 35-year disease risk and sequence of events.. Journal of Clinical Oncology. 32(15_suppl). 9505–9505. 2 indexed citations
19.
Aleman, Berthe M.P., Frederika A. van Nimwegen, Michael Schaapveld, et al.. (2014). Cardiovascular Diseases After Hodgkin Lymphoma Treatment: 35-Year Disease Risk and Sequence of Events. International Journal of Radiation Oncology*Biology*Physics. 90(1). S65–S65. 1 indexed citations
20.
Eggermond, Anna M. van, Michael Schaapveld, Cécile P.M. Janus, et al.. (2013). 167 Subsite Specific Risk of Colorectal Cancer Risk in Patients Treated for Hodgkin's Lymphoma: A Long-Term Follow-up Study in the Netherlands. Gastroenterology. 144(5). S–39. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maja V. Maraldo Breakdown of academic impact, for papers by Wil V. Dolsma Breakdown of academic impact, for papers by Robert G. Prosnitz Breakdown of academic impact, for papers by Torgil R. Möller Breakdown of academic impact, for papers by U. Blom-Goldman Breakdown of academic impact, for papers by Jennifer Wilkinson Breakdown of academic impact, for papers by Anton Kruger Breakdown of academic impact, for papers by Neil K. Taunk Breakdown of academic impact, for papers by Akthar Shamsaldin Breakdown of academic impact, for papers by M. Beauduin
Rankless by CCL
2026